BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28159900)

  • 1. Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding.
    Ranganathan P; Ngankeu A; Zitzer NC; Leoncini P; Yu X; Casadei L; Challagundla K; Reichenbach DK; Garman S; Ruppert AS; Volinia S; Hofstetter J; Efebera YA; Devine SM; Blazar BR; Fabbri M; Garzon R
    J Immunol; 2017 Mar; 198(6):2500-2512. PubMed ID: 28159900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease.
    Zitzer NC; Garzon R; Ranganathan P
    Front Immunol; 2018; 9():2561. PubMed ID: 30455702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ex Vivo Treatment of Donor T Cells with Cosalane, an HIV Therapeutic and Small-Molecule Antagonist of CC-Chemokine Receptor 7, Separates Acute Graft-versus-Host Disease from Graft-versus-Leukemia Responses in Murine Hematopoietic Stem Cell Transplantation Models.
    Fowler KA; Li K; Whitehurst CB; Bruce DW; Moorman NJ; Aubé J; Coghill JM
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1062-1074. PubMed ID: 30668984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.
    Xiao B; Wang Y; Li W; Baker M; Guo J; Corbet K; Tsalik EL; Li QJ; Palmer SM; Woods CW; Li Z; Chao NJ; He YW
    Blood; 2013 Nov; 122(19):3365-75. PubMed ID: 24041574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.
    Sang W; Zhang C; Zhang D; Wang Y; Sun C; Niu M; Sun X; Zhou C; Zeng L; Pan B; Chen W; Yan D; Zhu F; Wu Q; Cao J; Zhao K; Chen C; Li Z; Li D; Loughran TP; Xu K
    Am J Hematol; 2015 Nov; 90(11):998-1007. PubMed ID: 26223969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.
    Gimondi S; Dugo M; Vendramin A; Bermema A; Biancon G; Cavané A; Corradini P; Carniti C
    Exp Hematol; 2016 Jul; 44(7):624-634.e1. PubMed ID: 27013207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects.
    Liu Y; Wu Y; Wang Y; Cai Y; Hu B; Bao G; Fang H; Zhao L; Ma S; Cheng Q; Song Y; Liu Y; Zhu Z; Chang H; Yu X; Sun A; Zhang Y; Vignali DA; Wu D; Liu H
    Leukemia; 2015 Apr; 29(4):939-46. PubMed ID: 25363669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine- 2,3-dioxygenase.
    Zhao XS; Wang YN; Lv M; Kong Y; Luo HX; Ye XY; Wu Q; Zhao TF; Hu YH; Zhang HY; Huo MR; Wan J; Huang XJ
    Oncotarget; 2016 Jul; 7(30):48321-48334. PubMed ID: 27340781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor-κB1 and MicroRNA-146a polymorphisms and risk of acute graft versus host disease post allogeneic stem cell transplantation.
    Mossallam GI; Fattah RA; Mahmoud HK
    Immunobiology; 2020 Mar; 225(2):151876. PubMed ID: 31813598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma microRNA-586 is a new biomarker for acute graft-versus-host disease.
    Wang Y; Zhao X; Ye X; Luo H; Zhao T; Diao Y; Zhang H; Lv M; Zhang W; Huang X; Wan J
    Ann Hematol; 2015 Sep; 94(9):1505-14. PubMed ID: 26051902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum microRNA181a: Correlates with the intracellular cytokine levels and a potential biomarker for acute graft-versus-host disease.
    Xie L; Zhou F; Liu X; Fang Y; Yu Z; Song N; Kong F
    Cytokine; 2016 Sep; 85():37-44. PubMed ID: 27288630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma MiR-181b and MiR-194 As Biomarkers for Acute Graft- Versus-Host Disease and Significance of Their Changes].
    Chen Y; Deng HL; Kang DL; Wang Y; Hong XL; Lu QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):957-962. PubMed ID: 34105500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of selected serum microRNAs for acute GVHD by TaqMan MicroRNA arrays.
    Zhang C; Bai N; Huang W; Zhang P; Luo Y; Men S; Wen T; Tong H; Wang S; Tian YP
    Ann Hematol; 2016 Oct; 95(11):1833-43. PubMed ID: 27553380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling Tissue and Biofluid miR-155-5p, miR-155
    Crossland RE; Norden J; Ghimire S; Juric MK; Pearce KF; Lendrem C; Collin M; Mischak-Weissinger E; Holler E; Greinix HT; Dickinson AM
    Front Immunol; 2021; 12():639171. PubMed ID: 33790910
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correlation between Plasma microRNA Expression and Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation].
    Hu B; Fu W; Huang SY; Gao XT; Li DH; Yan XQ; Zhang YP; Liu Q; Liu L; Liang YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):827-32. PubMed ID: 27342518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
    Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic factors are associated with development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Nie DM; Wu QL; Zhu XX; Zhang R; Zheng P; Fang J; You Y; Zhong ZD; Xia LH; Hong M
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):694-699. PubMed ID: 26489624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ex vivo toll-like receptor 7 tolerance induction in donor lymphocytes prevents murine acute graft-versus-host disease.
    Zogas N; Karponi G; Iordanidis F; Malasidis S; Paraskevas V; Papadopoulou A; Scouras ZG; Anagnostopoulos A; Yannaki E
    Cytotherapy; 2018 Jan; 20(1):149-164. PubMed ID: 29150086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation.
    Visentainer JE; Lieber SR; Persoli LB; Vigorito AC; Aranha FJ; de Brito Eid KA; Oliveira GB; Miranda EC; de Souza CA
    Exp Hematol; 2003 Nov; 31(11):1044-50. PubMed ID: 14585368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miR-455-3p, miR-5787, and miR-548a-3p as potential noninvasive biomarkers in the diagnosis of acute graft-versus-host disease: a validation study.
    Motaei J; Kerachian MA; Mousavi SA; Alimoghadam K; Ghavamzadeh A; Manoochehrabadi S; Ahmadvand M; Yaghmaie M
    Ann Hematol; 2021 Oct; 100(10):2621-2631. PubMed ID: 34247256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.